SEC Form 4 · accession 0001609351-18-000028
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elliot Sigal
Director
Period of report
Oct 12, 2017
Accepted (ET)
Apr 16, 2018 · 5:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 12, 2017 | P | 29 | $90.75 | A | 11,243 | D | |
| Common StockF1 | Nov 28, 2017 | S | 29 | $72.43 | D | 11,214 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects transactions occurring in a brokerage account managed by an investment advisor who maintained discretionary authority over the account. The transactions were made by the investment advisor in contradiction of the Reporting Person's instructions and without the Reporting Person's approval.